Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2000281	注射用重组人白介素-2	Recombinant Human Interleukin-2	Lyophilized	Biological Products	Supplementary Application	2020-11-12	江苏金丝利药业股份有限公司	Jiangsu Kingsley Pharmaceutical Co Ltd	Certificate Issued	2021-02-03	view
CYSB2000280	注射用重组人白介素-2	Recombinant Human Interleukin-2	Lyophilized	Biological Products	Supplementary Application	2020-11-12	江苏金丝利药业股份有限公司	Jiangsu Kingsley Pharmaceutical Co Ltd	Certificate Issued	2021-02-03	view
CYSB2000279	注射用重组人白介素-2	Recombinant Human Interleukin-2	Lyophilized	Biological Products	Supplementary Application	2020-11-12	江苏金丝利药业股份有限公司	Jiangsu Kingsley Pharmaceutical Co Ltd	Certificate Issued	2021-02-03	view
CYSB2000278	注射用重组人白介素-2	Recombinant Human Interleukin-2	Lyophilized	Biological Products	Supplementary Application	2020-11-12	江苏金丝利药业股份有限公司	Jiangsu Kingsley Pharmaceutical Co Ltd	Certificate Issued	2021-02-03	view
CXHL1800032	注射用苏拉明钠		Lyophilized	Chemical Drugs(2.4)	New Drug Application	2018-04-02	江苏金丝利药业股份有限公司	Jiangsu Kingsley Pharmaceutical Co Ltd	Certificate Issued	2018-07-13	view